None
Quote | Medipharm Labs Corp (OTCMKTS:MEDIF)
Last: | $0.0575 |
---|---|
Change Percent: | -4.49% |
Open: | $0.064 |
Close: | $0.0602 |
High: | $0.067 |
Low: | $0.0575 |
Volume: | 8,375 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Medipharm Labs Corp (OTCMKTS:MEDIF)
2024-03-27 15:20:26 ET MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Conference Call March 27, 2024 08:30 ET Company Participants David Pidduck - Chief Executive Officer Keith Strachan - President Greg Hunter - Chief Financial Officer Conference Call Partic...
MediPharm Labs Provides Conference Call Recording Details Canada NewsWire TORONTO , March 27, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in prec...
Message Board Posts | Medipharm Labs Corp (OTCMKTS:MEDIF)
Subject | By | Source | When |
---|---|---|---|
Medipharm Labs Provides Update on VIVO integration and | Excalibur13 | investorshub | 04/13/2023 2:52:00 PM |
$MEDIF: effective April 5,2023: Plan of Arrangement. Shareholders | Renee | investorshub | 04/04/2023 1:06:15 PM |
Medipharm Completes Acquisition of VIVO Cannabis. | Excalibur13 | investorshub | 04/03/2023 2:07:18 PM |
Medipharm sets date for 4th QTR and full | Excalibur13 | investorshub | 03/29/2023 3:18:21 PM |
MediPharm Labs Corp. Announces Voting Results From Special | Excalibur13 | investorshub | 03/22/2023 4:09:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Medipharm Labs Corp Company Name:
MEDIF Stock Symbol:
OTCMKTS Market:
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results on Wednesday for the full year and three months ended Dec....
MediPharm Labs Provides Conference Call Recording Details Canada NewsWire TORONTO , March 27, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in prec...
MediPharm Labs Reports Fourth Quarter and Full Year Results PR Newswire Annual Revenue and Adjusted EBITDA Improve by 50% TORONTO , March 27, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Com...